Poly(2-ethyl-2-oxazoline)-Conjugated Hemoglobins as a Red Blood Cell Substitute

ACS Appl Bio Mater. 2023 Aug 21;6(8):3330-3340. doi: 10.1021/acsabm.3c00392. Epub 2023 Jul 28.

Abstract

Hemoglobin wrapped covalently with poly(2-ethyl-2-oxazoline)s (POx-Hb) is characterized physicochemically and physiologically as an artificial O2 carrier for use as a red blood cell (RBC) substitute. The POx-Hb is generated by linkage of porcine Hb surface-lysines to a sulfhydryl terminus of the POx derivative, with the average binding number of the polymers ascertained as 6. The POx-Hb shows moderately higher colloid osmotic activity and O2 affinity than the naked Hb. Human adult HbA conjugated with POx also possesses equivalent features and O2 binding properties. The POx-Hb solution exhibits good hemocompatibility, with no influence on the functions of platelets, granulocytes, and monocytes. Its circulation half-life in rats is 14 times longer than that of naked Hb. Hemorrhagic shock in rats is relieved sufficiently by infusion of the POx-Hb solution, as revealed by improvements of circulatory parameters. Serum biochemistry tests and histopathological observations indicate no acute toxicity or abnormality in the related organs. All results indicate that POx-Hb represents an attractive alternative for RBCs and a useful O2 therapeutic reagent in transfusion medicine.

Keywords: O2 affinity; artificial blood; blood compatibility; hemoglobin-based O2 carrier; polyoxazoline; resuscitation from hemorrhagic shock.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Substitutes* / chemistry
  • Blood Substitutes* / metabolism
  • Blood Substitutes* / pharmacology
  • Erythrocytes / metabolism
  • Hemoglobins* / chemistry
  • Hemoglobins* / pharmacology
  • Hemoglobins* / therapeutic use
  • Humans
  • Oxazoles / metabolism
  • Rats
  • Swine

Substances

  • 2-ethyl-2-oxazoline
  • poly(2-ethyl-2-oxazoline)
  • Hemoglobins
  • Oxazoles
  • Blood Substitutes